![](/img/cover-not-exists.png)
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer
Dino Amadori, Rosella Silvestrini, Mario De Lena, Francesco Boccardo, Andrea Rocca, Emanuela Scarpi, Francesco Schittulli, Mario Brandi, Roberta Maltoni, Patrizia Serra, Riccardo Ponzone, Nicoletta BiVolume:
125
Language:
english
Pages:
10
DOI:
10.1007/s10549-010-1257-5
Date:
February, 2011
File:
PDF, 485 KB
english, 2011